Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-31 @ 11:47 PM
Study NCT ID:
NCT00434356
Status:
TERMINATED
Last Update Posted:
2009-12-03
First Post:
2007-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)
Sponsor:
Genentech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AVF4057g
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Jai Balkissoon, M.D., Study Director
Old Organization:
Genentech, Inc.